This issue highlights microfluidic assays for the quantification of cell migration and proliferation to categorize patients with glioblastoma, for tracking the expression of therapeutic protein targets in circulating tumour cells from patients, and for the real-time measurement of glucose and insulin continuously in mice. It also highlights microneedles for the quantification of protein biomarkers in interstitial fluid, the classification of T-cell activation by measuring autofluorescence lifetimes, the mechanopharmacological conditioning of human stromal cells to enhance vascular regeneration, and epigenetic effects of extracellular-matrix stiffness in gastric tumours.

原文链接

https://www.nature.com/natbiomedeng/volumes/5/issues/1